GenomeKey
GenomeKey is a pioneering company focused on transforming diagnostics for sepsis through its next-generation IVD device. This innovative technology allows for rapid identification of bacteria and provides a comprehensive antimicrobial resistance profile directly from patient blood within hours. By significantly reducing the time to diagnosis and improving accuracy, GenomeKey aims to empower clinicians to deliver targeted treatments, ultimately saving lives. Founded in 2019, the company has proven its technology and is actively engaging with global healthcare systems to demonstrate its clinical benefits, positioning itself as a leader in the fight against sepsis.
GenomeKey
GenomeKey is a pioneering company focused on transforming diagnostics for sepsis through its next-generation IVD device. This innovative technology allows for rapid identification of bacteria and provides a comprehensive antimicrobial resistance profile directly from patient blood within hours. By significantly reducing the time to diagnosis and improving accuracy, GenomeKey aims to empower clinicians to deliver targeted treatments, ultimately saving lives. Founded in 2019, the company has proven its technology and is actively engaging with global healthcare systems to demonstrate its clinical benefits, positioning itself as a leader in the fight against sepsis.